BI 2536 Second Line Monotherapy in SCLC

A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

NCT03472053 ·Status: COMPLETED ·Phase: PHASE2

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

NCT00418743 ·Status: UNKNOWN

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

NCT07110363 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

NCT04429087 ·Status: RECRUITING ·Phase: PHASE1

Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer

NCT01090830 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer.

NCT00160043 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

NCT00445198 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects

NCT04939662 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer

NCT00160069 ·Status: COMPLETED ·Phase: PHASE2

Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy

NCT00100256 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)

NCT00656136 ·Status: COMPLETED ·Phase: PHASE3

Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer

NCT02182102 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients

NCT00044538 ·Status: COMPLETED ·Phase: PHASE2

A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer

NCT04890795 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT07111520 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

NCT01138163 ·Status: COMPLETED ·Phase: PHASE2

A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer

NCT02182232 ·Status: COMPLETED ·Phase: PHASE1

A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

NCT05026593 ·Status: COMPLETED ·Phase: PHASE1

Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection

NCT02199886 ·Status: TERMINATED ·Phase: PHASE1

A Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy Progression

NCT07289048 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer

NCT00400803 ·Status: COMPLETED ·Phase: PHASE2

BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer

NCT00098254 ·Status: COMPLETED ·Phase: PHASE2

An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT02522910 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer

NCT02250326 ·Status: COMPLETED ·Phase: PHASE2

Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

NCT02503358 ·Status: COMPLETED ·Phase: PHASE1